Speaker illustration

Professor Yu Jie Zhou

Beijing AnZhen Hospital affiliated to Capital Medical University, Beijing (China)

Member of:

European Society of Cardiology

Active-target liposomal drug shows significant atherosclerotic plaque regression effect: a proof-of-concept phase 1b/2a clinical trial

Event: ESC Congress 2025

Topic: Pharmacotherapy

Session: Atherosclerosis: prevention and new regression

Thumbnail

Tailoring antithrombotic therapy in acute coronary syndromes in the Asian population

Event: ESC Congress 2019

Topic: Treatment

Session: Antithrombotic therapy in patients with acute coronary syndromes

Thumbnail